This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Piers Gaffney, PhD
Chief Scientific Officer & VP of Research at Exactmer
Speaker

Profile

Piers holds a PhD from Kings College London, with a PostDoc from UCL, and specializes in oligonucleotide and phospholipid synthesis. With expertise in phosphorylated metabolites, he led chemistry in the Livingston Group from 2012 to 2019, focusing on innovative research. Named on 13 patents in Nanostar Sieving, he currently spearheads groundbreaking research and development efforts at Exactmer.

Agenda Sessions

  • Fully Liquid Phase, Membrane-Assisted Oligonucleotide Synthesis

    10:10am